2006
DOI: 10.1183/09031936.00060205
|View full text |Cite
|
Sign up to set email alerts
|

Eotaxin-2 in sputum cell culture to evaluate asthma inflammation

Abstract: The aim of the present study was to elucidate whether the culture of cells recovered from induced sputum may represent a suitable model to evaluate cytokine and chemokine production by airway inflammatory cells.Sputum induction was performed in 21 normal subjects and 30 asthmatic patients. A total of 21 out of the 30 asthmatic patients were taking inhaled corticosteroids, while the remaining nine were steroid-naive asthmatics. The steroid-naive group was evaluated before and after a 14-day treatment with oral … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
10
0
1

Year Published

2008
2008
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(14 citation statements)
references
References 41 publications
(39 reference statements)
3
10
0
1
Order By: Relevance
“…In our study, there was a significant correlation between eotaxin levels and percentage eosinophils in patients with asthma. These results concur with Scheicher et al.’s findings (24). Fujisawa et al.…”
Section: Discussionsupporting
confidence: 94%
“…In our study, there was a significant correlation between eotaxin levels and percentage eosinophils in patients with asthma. These results concur with Scheicher et al.’s findings (24). Fujisawa et al.…”
Section: Discussionsupporting
confidence: 94%
“…This sustained expression is surprising given the reported suppression of IL-4/IL-13-stimulated eotaxins by CS in vitro and in those with mild asthma treated with oral CS. 113031 To address this, IL-13-treated epithelial cells were treated with dexamethasone for 48 h. Although IL-13-stimulated eotaxin-2 and eotaxin-3 protein were consistently suppressed by CSs, the overall decrease was small (25%). Thus, although in simple cell culture systems there is consistent suppression, the translation of this to the more complicated in vivo setting is unclear.…”
Section: Discussionmentioning
confidence: 99%
“…11,12 Eotaxin is a key mediator for intrapulmonary eosinophil accumulation and development of lung injury. Eotaxin-2/CCL24 is a potent eosinophil chemoattractant in vitro and in vivo ,13–15 similarly to eotaxin-1,16 and is increased in sputum cell cultures from patients with asthma 17. More recently, a range of non-CCR3-binding chemokines, which are able to influence eosinophil function, has been identified, including CCL3 (macrophage inflammatory protein-1α) and CCL22 (macrophage-derived chemokine) 18.…”
Section: Discussionmentioning
confidence: 99%